一般演題示説 第3分科会

[P03-12(31AM087)] 経口グルココルチコイド治療中断後の骨折リスク低下の様相とリスク上昇の継続期間

*Masayuki Iki^1,8, Kenji Fujimori^2,8, Shinichi Nakatoh^3,8, Nobukazu Okimoto^4,8, Junko Tamaki^5,8, Shigeyuki Ishii^6,8, Hironori Imano¹, Sumito Ogawa^7,8 (1. Department of Public Health, Kindai University Faculty of Medicine, 2. Department of Health Administration and Policy, Tohoku University School of Medicine, 3. Department of Orthopedic Surgery, Asahi General Hospital, 4. Okimoto Clinic, 5. Department of Hygiene and Public Health, Osaka Medical and Pharmaceutical University, 6. Department of Regulatory Science, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 7. Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, 8. NDBJ-Osteoporosis Management Study Group)